Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic polymorphism of CYP2D6 in Tamil population.

Literature DB >> 11294377

Genetic polymorphism of CYP2D6 in Tamil population.

B K Abraham, C Adithan, J Mohanasundaram, C H Shashindran, K Koumaravelou, M Asad.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2001 PMID： 11294377 DOI： 10.1007/s002280000231

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

10 in total

Review 1. Pharmacogenetics.

Authors: C R Wolf; G Smith
Journal: Br Med Bull Date: 1999 Impact factor: 4.291

2. Genetic polymorphism of CYP2D6 in a keralite (South India) population.

Authors: B K Abraham; C Adithan; C H Shashindran; S Vasu; N A Alekutty
Journal: Br J Clin Pharmacol Date: 2000-03 Impact factor: 4.335

3. Dextromethorphan O-demethylation polymorphism in an African-American population.

Authors: N He; H I Daniel; L Hajiloo; D Shockley
Journal: Eur J Clin Pharmacol Date: 1999-08 Impact factor: 2.953

4. Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India.

Authors: B K Abraham; C Adithan; P U Kiran; M Asad; K Koumaravelou
Journal: Acta Pharmacol Sin Date: 2000-06 Impact factor: 6.150

5. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences.

Authors: W J Tamminga; J Wemer; B Oosterhuis; J Weiling; B Wilffert; L F de Leij; R A de Zeeuw; J H Jonkman
Journal: Eur J Clin Pharmacol Date: 1999-05 Impact factor: 2.953

6. Polymorphism of dextromethorphan oxidation in South Indian subjects.

Authors: R N Mamidi; S Satyavageeswaran; S V Vakkalanka; M R Chaluvadi; K Katneni; N Brahmadevara; G Damodarram; S Subramaniam
Journal: Clin Pharmacol Ther Date: 1999-08 Impact factor: 6.875

7. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.

Authors: B Schmid; J Bircher; R Preisig; A Küpfer
Journal: Clin Pharmacol Ther Date: 1985-12 Impact factor: 6.875

8. High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection.

Authors: Y W Lam; S Y Rodriguez
Journal: Ther Drug Monit Date: 1993-08 Impact factor: 3.681

9. Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.

Authors: K Weerasuriya; R L Jayakody; C A Smith; C R Wolf; G T Tucker; M S Lennard
Journal: Br J Clin Pharmacol Date: 1994-11 Impact factor: 4.335

10. Genetic polymorphism of CYP2D6 in North Indian subjects.

Authors: V Lamba; J K Lamba; J B Dilawari; K K Kohli
Journal: Eur J Clin Pharmacol Date: 1998 Nov-Dec Impact factor: 2.953

10 in total

6 in total

1. Association of CYP2D6 100 C > T and 2850 C > T polymorphisms with generalized tonic clonic seizures among Indians.

Authors: C C Soundararajan; A Adhin; M Tripathi; H K Prasad; S Jain; S Vivekanandhan
Journal: J Neural Transm (Vienna) Date: 2006-07-13 Impact factor: 3.575

2. Genotype and allele frequency of CYP2D6 in Tamilian population.

Authors: C Adithan; N Gerard; A T Naveen; K Koumaravelou; C H Shashindran; R Krishnamoorthy
Journal: Eur J Clin Pharmacol Date: 2003-08-27 Impact factor: 2.953

3. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.

Authors: Dhakchinamoorthi Krishna Kumar; Deepak Gopal Shewade; Marie-Anne Loriot; Philippe Beaune; Jayaraman Balachander; B V Sai Chandran; Chandrasekaran Adithan
Journal: Eur J Clin Pharmacol Date: 2013-09-10 Impact factor: 2.953